Juha Taavela

A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease

Detlef Schuppan, Markku Mäki, Knut E. A. Lundin et al. · New England Journal of Medicine · 2021 · 229 citations · Full text

Medicine, Immunology, Pharmacology +17

Validation of Morphometric Analyses of Small-Intestinal Biopsy Readouts in Celiac Disease

Juha Taavela, Outi Koskinen, Heini Huhtala et al. · PLoS ONE · 2013 · 206 citations · Full text

Medicine, Clinical Sciences, Pathology +17

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Gautam Goel, Tim King, A. James M. Daveson et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 144 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study

Marja‐Leena Lähdeaho, Mika Scheinin, Pekka Vuotikka et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 120 citations

Medicine, Immunology, Internal Medicine +14

Outcome measures in coeliac disease trials: the Tampere recommendations

Jonas F. Ludvigsson, Carolina Ciacci, Peter H.R. Green et al. · Gut · 2018 · 101 citations · Full text

Life Sciences, Immunology, Nutrition +16